10-11-2026 19:15 via MedPageToday.com - medical news for physicians

Cutaneous Sarcoidosis Could Soon Get an Effective Therapy

(MedPage Today) -- ORLANDO--Patients with cutaneous sarcoidosis--a condition with no very effective therapy--saw dramatic improvement with the dual-acting TYK2/JAK1 inhibitor brepocitinib (Lisraya) in a small phase II trial.
Patients...
Read more »

Medical Industry news



Metformin and Long COVID; Lp(a) Lowering for Cardiovascular Disease
An Insurer Paid Me $6.73 to Save a Teen's Life
Plastic Surgeon Convicted of Killing Lawyer Is Sentenced to Death
Alzheimer's Test Results Delivered Digitally Didn't Increase Distress
Court Approves $7.25B Settlement With Bayer Over Claims Roundup Caused Cancer
Insulin Resistance by Age 30 Quite Telling of Future Heart Health
'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment
Cancer Care Driving Insurance Costs; Unnecessary Chemo? Profiting by Non-Profits
Medicare for All Has Capitol Hill Abuzz, but It's Unlikely to Pass Soon, Experts Say
Why Is Noah Wyle of 'The Pitt' Making Headlines?
Novel Oral HAE Drug Measures Up to Injectable Options
Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial
Cardiovascular Screening Test Called Into Question
Can Tonsillectomy Help for Non-Asian Patients With IgA Nephropathy?
Desktop versie